Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | CMA1 | P23946 | 8/20 | 0.39 |
| ▸ | F2 | P00734 | 1/20 | 0.38 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.38 |
| ▸ | ELANE | P08246 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | STAT3 | P40763 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10903604 | 1.00 | KMT2A (0.46) | KMT2APOLBSMN1; SMN2CMA1F2 | |
| SCHEMBL10903575 | 0.89 | KMT2A (0.38) | KMT2ACMA1F2ELANESTAT3 | |
| SCHEMBL10903576 | 0.89 | KMT2A (0.38) | KMT2ACMA1F2ELANESTAT3 | |
| SCHEMBL10902844 | 0.84 | STAT3 (0.41) | KMT2AF2STAT3 | |
| SCHEMBL10902835 | 0.84 | STAT3 (0.41) | KMT2AF2STAT3 | |
| SCHEMBL10902010 | 0.82 | XPNPEP1 (0.39) | KMT2APOLBSMN1; SMN2 | |
| SCHEMBL10902001 | 0.82 | XPNPEP1 (0.39) | KMT2APOLBSMN1; SMN2 | |
| SCHEMBL31186018 | 0.72 | KMT2A (0.78) | KMT2APOLBSMN1; SMN2CMA1MEN1 | |
| SCHEMBL29359618 | 0.72 | KMT2A (0.78) | KMT2APOLBSMN1; SMN2CMA1MEN1 | |
| SCHEMBL10903691 | 0.71 | KMT2A (0.37) | KMT2AF2STAT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4596819-A | Antidepressive agents | WARNER-LAMBERT COMPANY (US) | 1986-06-24 | — | — | US | disclosed |